Ross Leonard S 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jun 29, 2018
Insider Transaction Report
Form 4
Ross Leonard S
Corporate Controller
Transactions
- Exercise/Conversion
Restricted Stock Units
2018-06-27−6,666→ 13,334 total→ Common Stock (6,666 underlying) - Tax Payment
Common Stock
2018-06-27$1.86/sh−1,904$3,541→ 14,762 total - Exercise/Conversion
Common Stock
2018-06-27+6,666→ 16,666 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F3]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the insider's exercise of his withholding right following the vesting of the restricted stock units.